Skip to main content
Journal cover image

Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes.

Publication ,  Journal Article
Coogan, AC; Williams, MD; Krishnan, V; Skertich, NJ; Becerra, AZ; Sarran, M; Schimpke, S; Torquati, A; Omotosho, P
Published in: Obes Surg
August 2023

BACKGROUND: Rapid weight loss after bariatric surgery is a risk factor for gallstone development. Numerous studies have shown that ursodiol after surgery decreases rates of gallstone formation and cholecystitis. Real-world prescribing practices are unknown. This study aimed to examine prescription patterns for ursodiol and reassess its impact on gallstone disease using a large administrative database. METHODS: The Mariner database (PearlDiver, Inc.) was queried using Current Procedural Terminology codes for Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) between 2011 and 2020. Only patients with International Classification of Disease codes for obesity were included. Patients with pre-operative gallstone disease were excluded. The primary outcome was gallstone disease within 1 year, which was compared between patients who did and did not receive an ursodiol prescription. Prescription patterns were also analyzed. RESULTS: Three hundred sixty-five thousand five hundred patients fulfilled inclusion criteria. Twenty-eight thousand seventy-five (7.7%) patients were prescribed ursodiol. There was a statistically significant difference in development of gallstones (p < 0.001), development of cholecystitis (p = .049), and undergoing cholecystectomy (p < 0.001). There was a statistically significant decrease in the adjusted odds ratio (aOR) for the development of gallstones (aOR 0.81, 95% CI: 0.74, 0.89), development of cholecystitis (aOR 0.59, 95% CI: 0.36, 0.91), and undergoing cholecystectomy (aOR 0.75, 95% CI: 0.69, 0.81). CONCLUSION: Ursodiol significantly decreases the odds of development of gallstones, cholecystitis, or cholecystectomy within 1 year following bariatric surgery. These trends hold true when analyzing RYGB and SG separately. Despite the benefit of ursodiol, only 10% of patients received an ursodiol prescription postoperatively in 2020.

Duke Scholars

Published In

Obes Surg

DOI

EISSN

1708-0428

Publication Date

August 2023

Volume

33

Issue

8

Start / End Page

2361 / 2367

Location

United States

Related Subject Headings

  • Ursodeoxycholic Acid
  • Surgery
  • Retrospective Studies
  • Postoperative Complications
  • Obesity, Morbid
  • Humans
  • Gastric Bypass
  • Gastrectomy
  • Gallstones
  • Cholecystitis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Coogan, A. C., Williams, M. D., Krishnan, V., Skertich, N. J., Becerra, A. Z., Sarran, M., … Omotosho, P. (2023). Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes. Obes Surg, 33(8), 2361–2367. https://doi.org/10.1007/s11695-023-06710-3
Coogan, Alison C., Michael D. Williams, Vaishnavi Krishnan, Nicholas J. Skertich, Adan Z. Becerra, Marc Sarran, Scott Schimpke, Alfonso Torquati, and Philip Omotosho. “Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes.Obes Surg 33, no. 8 (August 2023): 2361–67. https://doi.org/10.1007/s11695-023-06710-3.
Coogan AC, Williams MD, Krishnan V, Skertich NJ, Becerra AZ, Sarran M, et al. Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes. Obes Surg. 2023 Aug;33(8):2361–7.
Coogan, Alison C., et al. “Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes.Obes Surg, vol. 33, no. 8, Aug. 2023, pp. 2361–67. Pubmed, doi:10.1007/s11695-023-06710-3.
Coogan AC, Williams MD, Krishnan V, Skertich NJ, Becerra AZ, Sarran M, Schimpke S, Torquati A, Omotosho P. Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes. Obes Surg. 2023 Aug;33(8):2361–2367.
Journal cover image

Published In

Obes Surg

DOI

EISSN

1708-0428

Publication Date

August 2023

Volume

33

Issue

8

Start / End Page

2361 / 2367

Location

United States

Related Subject Headings

  • Ursodeoxycholic Acid
  • Surgery
  • Retrospective Studies
  • Postoperative Complications
  • Obesity, Morbid
  • Humans
  • Gastric Bypass
  • Gastrectomy
  • Gallstones
  • Cholecystitis